Abrocitinib can help achieve minimal disease activity in patients with atopic dermatitis irrespective of previous exposure to ...

FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...

LEO Pharma announces key results of Phase 2 TRAPEDS-1 trial evaluating pharmacokinetics and safety of tralokinumab ...

Diagnosis and management of atopic dermatitis, a type of eczema, are complicated by skin temperature fluctuations, unclear ...

Add Yahoo as a preferred source to see more of our stories on Google. Considered in the past to be primarily a children's condition, atopic dermatitis can affect people of all ages If you’re over 60 ...

Arcutis Biotherapeutics said the U.S. Food and Drug Administration has accepted its application seeking expanded approval of its Zoryve topical treatment for infants with atopic dermatitis, the most ...

Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies ...

Turn Therapeutics (NASDAQ:TTRX) outlined the final stage two design and data-driven expansion of its GX-03 phase II program ...

Flaky scalp, itchiness and painful patches can all be signs of scalp dermatitis, an inflammation of the scalp that can have as many causes as it does symptoms. In most cases, it's not a serious ...

Kymera Therapeutics Inc. KYMR shares are trading higher by more than 21% on Thursday as the company has completed enrollment in its BROADEN2 Phase 2b trial for KT-621, a treatment for moderate to ...

Dupilumab demonstrated robust efficacy, durable benefits, and a favorable safety profile in children with moderate-to-severe ...

Watch rot' is trending online, but experts warn smartwatch overuse may cause contact dermatitis. Learn the symptoms, causes ...